117 related articles for article (PubMed ID: 1788830)
21. Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.
Avellone G; Di Garbo V; Cordova R; Raneli G; De Simone R; Bompiani GD
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):429-33. PubMed ID: 8329569
[TBL] [Abstract][Full Text] [Related]
22. Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.
Aitchison R; Chu P; Cater DR; Harris RJ; Powell RJ
Ann Rheum Dis; 1989 Jul; 48(7):590-3. PubMed ID: 2505697
[TBL] [Abstract][Full Text] [Related]
23. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
24. Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.
Poredos P; Stegnar M; Gacnik A
Vasa; 1999 May; 28(2):106-11. PubMed ID: 10409921
[TBL] [Abstract][Full Text] [Related]
25. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement.
Killewich LA; Macko RF; Cox K; Franklin DR; Benjamin ME; Lilly MP; Flinn WR
J Vasc Surg; 1997 Nov; 26(5):861-8. PubMed ID: 9372826
[TBL] [Abstract][Full Text] [Related]
26. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW
Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391
[TBL] [Abstract][Full Text] [Related]
27. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
28. A study of the fibrinolytic response in healthy men and women following a brief exposure to venous occlusion.
Lacroix KA; Bean C; Box L; Wagner K
Thromb Res; 1996 Jan; 81(1):133-43. PubMed ID: 8747528
[TBL] [Abstract][Full Text] [Related]
29. Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion.
Cugno M; Uziel L; Fabrizi I; Bottasso B; Maggiolini F; Agostoni A
Thromb Res; 1989 Dec; 56(5):625-34. PubMed ID: 2516662
[TBL] [Abstract][Full Text] [Related]
30. The extrinsic fibrinolytic system in survivors of myocardial infarction.
Nilsson TK; Johnson O
Thromb Res; 1987 Dec; 48(6):621-30. PubMed ID: 3124290
[TBL] [Abstract][Full Text] [Related]
31. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
Declerck PJ; Mombaerts P; Holvoet P; De Mol M; Collen D
Thromb Haemost; 1987 Dec; 58(4):1024-9. PubMed ID: 3127914
[TBL] [Abstract][Full Text] [Related]
32. Sensitive and direct assays for functionally active plasminogen activators (tissue-type and urokinase-type) in plasma.
Mahmoud-Alexandroni M; Heath AB; Gaffney PJ
Am J Clin Pathol; 1989 Sep; 92(3):308-14. PubMed ID: 2505607
[TBL] [Abstract][Full Text] [Related]
33. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
Stalder M; Hauert J; Bachmann F
Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
[TBL] [Abstract][Full Text] [Related]
34. Comparison of fibrinolytic activity in the femoral vein and the right atrium.
Sabovic M; Prevodnik VK; Keber D
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):245-8. PubMed ID: 15060421
[TBL] [Abstract][Full Text] [Related]
35. Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy.
Grulich-Henn J; Loechelt K; Speiser W; Müller-Berghaus G
Blut; 1989 Jan; 58(1):39-43. PubMed ID: 2492837
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study.
Giurgea GA; Brunner-Ziegler S; Jilma B; Sunder-Plassmann R; Koppensteiner R; Gremmel T
Thromb Res; 2017 May; 153():71-75. PubMed ID: 28347810
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis.
Stegnar M; Bozic B; Peternel P; Kveder T; Vene N; Rozman B
Thromb Res; 1991 Aug; 63(4):433-43. PubMed ID: 1754996
[TBL] [Abstract][Full Text] [Related]
38. A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic states.
Gaussem P; Gandrille S; Molho-Sabatier P; Capron L; Fiessinger JN; Aiach M
Thromb Haemost; 1990 Feb; 63(1):76-81. PubMed ID: 2111050
[TBL] [Abstract][Full Text] [Related]
39. Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery.
Mellbring G; Dahlgren S; Wiman B; Sunnegårdh O
Thromb Res; 1985 Jul; 39(2):157-63. PubMed ID: 2411000
[TBL] [Abstract][Full Text] [Related]
40. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
